How much is Genesis Therapeutics worth in 2026?

Genesis Therapeutics has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Genesis Therapeutics raised?

Genesis Therapeutics has raised $327.4M in total funding across 1 funding rounds.

Genesis Therapeutics

Drug DiscoveryWebsite

Genesis Therapeutics valuation and funding history | Last updated: November 13, 2024 | 1 funding rounds

Current Valuation

N/A

As of November 13, 2024

Total Funding Raised

$327.4M

Across 1 round

Last Round

Later Stage VC

$224.0M

Last Funding

Nov 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 25, 2023	Early Stage VC (Series B)	$224.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Genesis Therapeutics is currently valued at N/A as of November 13, 2024. The company has raised a total of $327.4M in funding across 1 funding round.

Track Genesis Therapeutics Valuation Updates

Get notified when Genesis Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Genesis Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Genesis Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Genesis Therapeutics Worth in 2026?

Genesis Therapeutics is a leading private company in the Drug Discovery sector. Track Genesis Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Genesis Therapeutics Valuation is Determined

Private company valuations like Genesis Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.